Related Experiment Video
Updated: Jun 26, 2026
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Treating hepatocellular carcinoma without liver transplantation
Sudhanshu Gogia1, Alex S Befeler
1Department of Internal Medicine, Division of Gastroenterology and Hepatology, Saint Louis University, 3635 Vista @ Grand FDT 9S, St. Louis, MO 63110, USA.
Current Gastroenterology Reports
|January 27, 2009
Summary
Hepatocellular carcinoma treatment varies by tumor size, location, and liver function. Options range from liver transplantation and surgery for early stages to chemoembolization and targeted therapy for advanced disease.
Area of Science:
- Hepatology
- Oncology
- Gastroenterology
Background:
- Hepatocellular carcinoma (HCC) is a global health concern, frequently developing in patients with cirrhosis.
- Treatment decisions for HCC are complex, hinging on tumor characteristics and the patient's liver reserve.
Purpose of the Study:
- To outline the current treatment strategies for hepatocellular carcinoma based on disease stage and patient condition.
- To provide a comprehensive overview of therapeutic options for HCC, guiding clinical decision-making.
Main Methods:
- Review of established treatment modalities for hepatocellular carcinoma.
- Categorization of treatments based on tumor size, location, hepatic reserve, and disease progression.
Main Results:
- Liver transplantation offers the best long-term survival but is limited by tumor size and donor availability.
- Surgical resection, percutaneous ethanol injection, and radiofrequency ablation are suitable for small, isolated tumors with adequate hepatic reserve.
- Chemoembolization is recommended for larger or multinodular tumors.
- Sorafenib provides modest survival benefits for advanced HCC with metastasis or portal vein invasion.
- Supportive care is indicated for patients with poor hepatic function or performance status.
Conclusions:
- Treatment selection for hepatocellular carcinoma requires careful consideration of individual patient factors and disease extent.
- A tailored approach, from transplantation to targeted therapy, is crucial for optimizing outcomes in HCC management.
